Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H.
Murakami M, et al. Among authors: ohe t.
J Cardiovasc Pharmacol. 2010 Oct;56(4):389-95. doi: 10.1097/FJC.0b013e3181f03c2f.
J Cardiovasc Pharmacol. 2010.
PMID: 20625312
Clinical Trial.